Lauxera Capital Partners
Growth investor in healthtech businesses at early profitability, across devices, digital health, diagnostics and health IT.
- Based in
- Paris, France
- Type
- Growth
- Stage
- Series B+
- Cheque size
- €20m-€100m
- Backs
- Women's & family health
- Business models
- Consumer app or subscription
- Recent deal
- Bridge To Life, organ preservation (August 2026)
Also backed
- Natural CyclesNon-hormonal contraception app
- LifenHealth data integration
- CaresyntaxSurgical intelligence platform
Get the full investor map.
Every finder match and founder checklist, plus an Excel download. Free with Healthier Notes.
Unlock the map